Explore trending stories, in-depth articles, and exclusive updates at AmeriPharmTimes
BORTEZOMIB: A New Formulation Revolutionizing Cancer Treatment Introduction Bortezomib is a potent drug used in the treatment of multiple myeloma and certain types of lymphoma. First approved by the FDA in 2003, bortezomib has been a cornerstone in cancer therapy, particularly for patients suffering from relapsed or refractory multiple myeloma. On August 26, 2024, the…
YUTREPIA: A New Milestone in Pulmonary Arterial Hypertension Treatment Introduction Pulmonary Arterial Hypertension (PAH) is a progressive and life-threatening condition that poses significant challenges in the medical community. The disease is characterized by high blood pressure in the arteries that supply the lungs, leading to symptoms such as shortness of breath, dizziness, and fatigue.…
FDA Grants Approval to Livdelzinda: A Breakthrough in Treating Primary Biliary Cholangitis Introduction On [August 15, 2024], the U.S. Food and Drug Administration (FDA) granted priority approval to Livdelzinda (SELADELPAR LYSINE), a groundbreaking new molecular entity developed by Cymabay Therapeutics for the treatment of primary biliary cholangitis (PBC). This approval marks a significant advancement in…
FDA Approval of Zurnai Autoinjector: A New Dosage Form of Nalmefene Hydrochloride Introduction On August 7, 2024, the U.S. Food and Drug Administration (FDA) granted approval for a new dosage form of nalmefene hydrochloride, marketed under the brand name Zurnai Autoinjector. This approval represents a significant advancement in the treatment of opioid overdose and…
Gabapentin Enacarbil & Oxycodone: Abuse Potential Revealed Introduction Gabapentin enacarbil is an extended-release prodrug of gabapentin, which is widely used in the treatment of conditions such as restless legs syndrome and postherpetic neuralgia. Oxycodone, on the other hand, is a potent opioid analgesic commonly prescribed for moderate to severe pain. Both medications have legitimate medical…
Understanding Lichen Sclerosus: Causes, Symptoms, Diagnosis, and Treatment Lichen sclerosus (LS) is a chronic, inflammatory skin condition that primarily affects the genital and anal regions, though it can also appear on other parts of the body. This article provides an in-depth look at lichen sclerosus, including its causes, symptoms, diagnosis, and treatment options, as well…
Contingent Staffing Agencies Operating from India In the dynamic and ever-evolving pharmaceutical industry, the need for specialized talent is paramount. As companies strive to maintain a competitive edge and meet regulatory requirements, many are turning to contingent staffing agencies, especially those based in India, to fulfill their workforce needs. This article delves into the reasons…
Introduction to Eslicarbazepine Eslicarbazepine acetate, marketed under the brand name Aptiom, is a medication primarily used to treat partial-onset seizures, a common type of epilepsy. Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked seizures, and it affects millions of people worldwide. Eslicarbazepine acetate, a prodrug of eslicarbazepine, is an anticonvulsant that works…
Daptomycin Introduction Daptomycin, marketed under the brand name Cubicin, is a cyclic lipopeptide antibiotic known for its unique mechanism of action and effectiveness against Gram-positive bacterial infections, including those caused by resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Approved by the FDA in 2003, Daptomycin has become a crucial tool…
The Landscape of Drug Development in the United States The development of new drugs is a complex, costly, and time-consuming process that is critical to advancing healthcare and improving patient outcomes. The United States, home to one of the most robust pharmaceutical industries in the world, plays a pivotal role in drug innovation and development.…